Use of Cervical Cap and Menstrual Disc for Application of Topical Anesthetic Prior to IUD Insertion

ConditionIUD
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorOregon Health and Science University

About this trial

This prospective, open label, double arm, feasibility group study will recruit participants planning to undergo office intrauterine device (IUD) placement without sedation or anxiolysis at the Center for Women's Health. Participants will self-administer a topical anesthetic using a contraceptive cervical cap or menstrual disc.

Twenty-four nulliparous women will be recruited to receive one of two administration methods immediately prior to IUD placement (12 subjects in each arm): 1) menstrual disc filled with 5g eutectic mixture of local anesthetics (EMLA) cream or 2) cervical cap filled with 5g EMLA cream.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Scheduled for IUD placement at the Center for Women's Health in Complex Family Planning clinic

Able to review and sign study consents in English

Generally healthy

Disqualifiers

History of any prior births, miscarriages, or abortions after 16 weeks' gestation

Currently pregnant, known or suspected

Current stringless IUD in place

Participants premedicated with misoprostol

Trial design

Design model

Parallel

Treatments tested in this trial

  • Menstrual disc with EMLA cream

    Combination product

    Eutectic mixture of local anesthetics (EMLA) cream self-administered using a menstrual disc

  • Cervical cap with EMLA cream

    Combination product

    Eutectic mixture of local anesthetics (EMLA) cream self-administered using a menstrual disc

Treatment groups

24 Participants
are divided into 2 treatment groups
Group A: Menstrual discExperimental treatment 1 intervention
Group B: Cervical capExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Successful Placement

The number of participants able to correctly place the cap or disc as instructed, assessed by provider

Time frame
Immediately after IUD placement procedure
2

Satisfaction with pain control

Participant-reported satisfaction with pain control for IUD placement using EMLA cream measured the Patient Acceptable Symptom State (PASS) methodology.

Time frame
Immediately after IUD placement procedure

Secondary outcomes

1

Ease of cap/disc placement

Participant-reported ease of placement of menstrual cap or disc. Response options will be "very easy", "somewhat easy", "neutral", "somewhat difficult", and "very difficult".

Time frame
Immediately after IUD placement procedure
2

Protocol deviations

Provider-reported deviations from the standard protocol including need for additional analgesia, oral pain medication, oral anxiolytic medication, need for cervical dilation, rescheduling with sedation per patient preference, or other.

Time frame
Immediately after IUD placement procedure
3

Ease of IUD placement

Provider-reported ease of IUD placement with response options "usual", "difficult", or "very difficult"

Time frame
Immediately after IUD placement procedure
4

Procedure complications

Provider-reported complications of IUD placement procedure including vagal reaction, perforation, placement failure, allergic reaction, or other.

Time frame
Immediately after IUD placement procedure

Other outcomes

1

Reasons for non-participation

For eligible prospective participants who were approached but declined participation, they will be asked the reason why they chose not to participate. This will be an open-ended response where the study staff member performing the screening will record the reason for declining participation.

Time frame
During screening/enrollment at the time when an eligible participant declines participation

Sponsors and contacts

Click on the lead sponsor to view all of their trials.